| Members |
targetComponentId |
| förvrider ansiktet |
Inappropriate movement of face |
| Scrofula |
Scrofuloderma |
| skrotumlambå |
Flap (substance) |
| Sebaceous epithelioma |
Sebaceous adenoma |
| isolerad miljö |
Secluded environment (finding) |
| biologisk andragradssläkting till patienten |
Second degree blood relative (person) |
| biologisk kvinnlig andragradssläkting till patienten |
Second degree female blood relative (person) |
| Second diphtheria and tetanus double vaccination |
Administration of second dose of diphtheria and tetanus vaccine |
| andra duplexvaccinationen mot difteri och stelkramp |
Administration of second dose of diphtheria and tetanus vaccine |
| Second diphtheria, pertussis and tetanus triple vaccination |
Administration of second dose of diphtheria, pertussis, and tetanus vaccine |
| andra trippelvaccinationen mot difteri, kikhosta och stelkramp |
Administration of second dose of diphtheria, pertussis, and tetanus vaccine |
| andra provröret klart |
Second glass clear |
| andra provröret innehåller mukus |
Second glass contains mucous (finding) |
| andra provröret innehåller prickar eller sediment |
Second glass contains specks or sediments |
| andra provröret innehåller trådar eller strängar |
Second glass contains threads or strands |
| lambå, tå II |
Flap (substance) |
| Secondary and unspec malig neop pulmonary lymph nodes |
Metastatic malignant neoplasm to lymph node (disorder) |
| sekundärt dedifferentierat intraosseöst ameloblastiskt karcinom |
Dedifferentiated intraosseous ameloblastic carcinoma (morphologic abnormality) |
| sekundärt dedifferentierat perifert ameloblastiskt karcinom |
Dedifferentiated peripheral ameloblastic carcinoma |
| sekundär sjukdom |
Disease |
| sekundärblödning orsakad av och efter illegalt framkallad abort |
Secondary haemorrhage due to and following induced termination of pregnancy |
| sekundärblödning orsakad av och efter legalt framkallad abort |
Secondary haemorrhage due to and following induced termination of pregnancy |
| Secondary hyperoxaluria |
Secondary oxalosis |
| Secondary hypogonadism |
Hypogonadotropic hypogonadism |
| sekundär idiopatisk telangiektasi |
Secondary telangiectasia (disorder) |
| Secondary localized osteoarthrosis of thigh |
Disorder of lower limb |
| Secondary malignant neoplasm of small intestine and duodenum |
Metastatic malignant neoplasm to small intestine |
| Secondary malignant neoplastic process |
Neoplasm, metastatic |
| Secondary nephrogenic diabetes insipidus |
Nephrogenic diabetes insipidus |
| Secondary operation NOC |
Surgical procedure (procedure) |
| sekundärt osteosarkom |
Secondary osteosarcoma following treatment or precursor disease (morphologic abnormality) |
| Secondary syphilis of other viscera |
Secondary syphilis of viscera |
| sekundär transvestism |
Secondary transvestism (finding) |
| sekretin 40 mikrogram, pulver till injektionsvätska, flaska |
Product containing only secretin in parenteral dose form (medicinal product form) |
| Secretory otitis media |
Chronic mucoid otitis media |
| sederande antihistamin |
Histamine receptor antagonist |
| biverkning av sederande antihistamin |
Adverse reaction to antihistamines |
| Sedative dependence |
Sedative dependence (disorder) |
| beroende av sedativ med nuvarande användning |
Sedative dependence (disorder) |
| anfall samtidigt med och orsakat av substansabstinens |
Seizure co-occurrent and due to substance withdrawal |
| klinisk handläggningsplan för sjukdom med krampanfall |
Seizure disorder clinical management plan |
| krampanfall, obestämt om fokalt eller generaliserat |
Epileptic seizure |
| Sejongia antarctica |
Chryseobacterium antarcticum (organism) |
| Sejongia jeonii |
Chryseobacterium jeonii (organism) |
| selegilin 1,25 mg, munsönderfallande tablett |
Product containing precisely selegiline hydrochloride 1.25 milligram/1 each conventional release orodispersible tablet (clinical drug) |
| selegilin 12 mg/24 timmar, depåplåster |
Selegiline 500 microgram/hour prolonged-release transdermal patch |
| selegilin 6 mg/24 timmar, depåplåster |
Product containing precisely selegiline 250 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
| selegilin 9 mg/24 timmar, depåplåster |
Selegiline 375 microgram/hour prolonged-release transdermal patch |
| selen 100 mikrogram/2 ml, oral lösning |
Product containing only selenium in oral dose form (medicinal product form) |
| selen 100 mikrogram/2 ml, injektionsvätska, lösning |
Product containing only selenium in parenteral dose form (medicinal product form) |
| selen 500 mikrogram/10 ml, oral lösning |
Product containing only selenium in oral dose form (medicinal product form) |
| selen 500 mikrogram/10 ml, injektionsvätska, lösning |
Product containing only selenium in parenteral dose form (medicinal product form) |
| självförvållad förgiftning med jordbrukskemikalie |
Self poisoning by herbicide (disorder) |
| självförvållad förgiftning med andra fasta eller flytande ämnen än läkemedel |
Self-administered poisoning |
| självframkallad abort |
Self-induced termination of pregnancy |
| Self-induced abortion |
Self-induced termination of pregnancy |
| seminom, kategori |
Malignant seminoma |
| seminom |
Malignant seminoma |
| senil dermatitis herpetiformis |
Dermatitis herpetiformis |
| Senile dermatitis herpetiformis |
Dermatitis herpetiformis |
| Senna |
Cassia acutifolia |
| senna 7,5 mg/5 ml, sockerfri sirap |
Senna only product in oral dose form |
| senna 7,5 mg/5 ml, oral sirap |
Senna only product in oral dose form |
| senna + isphagula 12,4 %/54,2 % granulat |
Psyllium and senna only product |
| Sensory nerve conduction study for velocity and/or latency |
Sensory nerve conduction study |
| Sensory skin flap NOS |
Sensory skin flap |
| portvaktslymfknuta |
Sentinel lymph node |
| separation av siamesiska tvillingar |
Separation of conjoined twins |
| sepsis under värkarbete med prenatal komplikation |
Sepsis during labor (disorder) |
| encefalopati i samband med sepsis |
Encephalopathy with sepsis |
| sepsisassocierad blödning i mag-tarmkanalen |
Gastrointestinal hemorrhage with sepsis |
| sepsisassocierad vänsterkammarsvikt |
Left ventricular failure with sepsis |
| sepsisassocierad lungskada |
Lung injury with sepsis |
| sepsisassocierad myokardiell dysfunktion |
Myocardial dysfunction with sepsis (disorder) |
| sepsisassocierad högerkammarsvikt |
Right ventricular failure with sepsis |
| sepsisrelaterad gastrit |
Gastritis with sepsis |
| sepsisrelaterade gastrointestinala lesioner |
Gastrointestinal lesion with sepsis |
| sepsisrelaterat gastrointestinalt sår |
Gastrointestinal ulceration due to sepsis |
| distorsion i näsans septumbrosk |
Injury of nasal septum |
| Septata |
Encephalitozoon |
| Septic abortion |
Sepsis following induced termination of pregnancy (disorder) |
| bakteroidsepsis |
Sepsis caused by Bacteroides (disorder) |
| indelning efter organsystem av följdtillstånd efter tidigare sjukdomar |
Disease |
| följdtillstånd efter sjukdom klassificerad efter sjukdomssystem |
Sequelae of disorders (disorder) |
| Serogroup Rift Valley Fever |
Sandfly fever Naples virus |
| Serogroup Sandfly Naples |
Sandfly fever Naples virus |
| Serogroup Sandfly Sicily |
Sandfly fever Sicilian virus (organism) |
| Serology: organism (& [bacteria] or [fungus] or [parasite] or [virus]) |
Specific antibody level - finding |
| Serology: organism (& [bacteria] or [fungus] or [parasite] or [virus]) |
Specific antibody level - finding |
| Serotonin uptake inhibitor |
Selective serotonin re-uptake inhibitor |
| seröst blod |
Serous discharge |
| Serous cystadenoma, borderline malignancy |
Serous cystadenoma, borderline malignancy |
| papillärt karcinom i slemhinna |
Serous cystadenocarcinoma |
| myokutan musculus serratus anterior-lambå samt revben |
Serratus anterior osteomyocutaneous flap of rib (substance) |
| Sertolicellstumör |
Sertoli cell tumor (morphologic abnormality) |
| Sertraline hydrochloride 25mg tablet |
Sertraline (as sertraline hydrochloride) 25 mg oral tablet |
| Sertraline hydrochloride 50mg tablet |
Product containing precisely sertraline (as sertraline hydrochloride) 50 milligram/1 each conventional release oral tablet (clinical drug) |
| onormal halt av 17-B-estriol i serum |
Estriol in serum outside reference range (finding) |
| mycket hög kolesterolhalt i serum |
Serum cholesterol above reference range |
| Serum cholesterol very high |
Serum cholesterol above reference range |
| Serum proteins NOS |
Measurement of protein in serum or plasma (procedure) |
FHIR